πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 110 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6939883

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Sep 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6933274

Methods for treatment of diabetes using a peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6921761

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6903106

Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-Ξ±]-pyrimidin-7-yl}phenyl)ac

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872728

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750350

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6747034

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6740638

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma

Neurocrine Biosciences, Inc. Β· Granted Tue May 25 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6740656

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue May 25 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723841

Corticotropin-releasing factor2 receptors

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723721

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6677340

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673796

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608197

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583143

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6562942

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. Β· Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6544999

Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-&agr;]- pyrimidin-9-yl}ph

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6541469

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Apr 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6537998

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6531475

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6514982

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500839

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489299

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma

Neurocrine Biosciences, Inc. Β· Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6485746

Controlled-release sedative-hypnotic compositions and methods related thereto

Neurocrine Biosciences, Inc. Β· Granted Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired